Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept A Rummel, T Eichner, T Weil, T Karnath, A Gutcaits, S Mahrhold, ... Proceedings of the National Academy of Sciences 104 (1), 359-364, 2007 | 209 | 2007 |
Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges I Kufareva, V Katritch, RC Stevens, R Abagyan Structure 22 (8), 1120-1139, 2014 | 181 | 2014 |
Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions M Lapinsh, P Prusis, A Gutcaits, T Lundstedt, JES Wikberg Biochimica et Biophysica Acta (BBA)-General Subjects 1525 (1-2), 180-190, 2001 | 167 | 2001 |
Mildronate: an antiischemic drug for neurological indications N Sjakste, A Gutcaits, I Kalvinsh CNS drug reviews 11 (2), 151-168, 2005 | 137 | 2005 |
Classification of G‐protein coupled receptors by alignment‐independent extraction of principal chemical properties of primary amino acid sequences M Lapinsh, A Gutcaits, P Prusis, C Post, T Lundstedt, JES Wikberg Protein Science 11 (4), 795-805, 2002 | 133 | 2002 |
Quinazolines and 1, 2, 4‐Benzothiadiazine 1, 1‐Dioxides. Part 8. Synthesis and Pharmacological Evaluation of Tricyclic Fused Quinazolines and 1, 2, 4‐Benzothiadiazine 1, 1 … JW CHERN, PL TAO, KC WANG, A GUTCAIT, SW LIU, MH YEN, ... ChemInform 29 (49), no-no, 1998 | 125* | 1998 |
Positive and negative modulation of group I metabotropic glutamate receptors M Vanejevs, C Jatzke, S Renner, S Müller, M Hechenberger, T Bauer, ... Journal of medicinal chemistry 51 (3), 634-647, 2008 | 63 | 2008 |
Studies on Quinazolines. Part 6. Asymmetric Synthesis of (S)‐(+)‐and (R)‐(‐)‐3‐((4‐(2‐Methoxyphenyl) piperazin‐1‐yl) methyl)‐5‐methylthio‐2, 3‐dihydroimidazo (1, 2‐c) quinazolines. A GUTCAIT, KC WANG, HW LIU, JW CHERN ChemInform 27 (42), no-no, 1996 | 41* | 1996 |
Hypothetical gamma-butyrobetaine esterase-dependent signal transduction system: possible link to mildronate action I Kalvinsh, A Gutcaits, L Bagdoniene, D Labeikyte, P Trapencieris, ... Med Hypotheses Res 3, 803-12, 2006 | 17 | 2006 |
Carrier for targeting nerve cells A Rummel, T Weil, A Gutcaits US Patent 8,481,040, 2013 | 16 | 2013 |
Allosteric modulation of family 3 GPCRs T Noeske, A Gutcaits, CG Parsons, T Weil QSAR & Combinatorial Science 25 (2), 134-146, 2006 | 16 | 2006 |
Substituted pyrazolo [1, 5-a] pyrimidines as metabotropic glutamate receptor modulators W Danysz, A Dekundy, M Hechenberger, M Henrich, C Jatzke, J Nagel, ... US Patent 7,947,689, 2011 | 9 | 2011 |
Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine W Danysz, A Dekundy, M Hechenberger, M Henrich, C Jatzke, J Nagel, ... EP Patent 2,295,439, 2011 | 9* | 2011 |
Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine W Danysz, A Dekundy, M Hechenberger, M Henrich, C Jatzke, J Nagel, ... EP Patent 2,054,416, 2011 | 9* | 2011 |
Quinazolines and 1, 2, 4‐Benzothiadiazine 1, 1‐Dioxides. Part 8. Synthesis and Pharmacological Evaluation of Tricyclic Fused Quinazolines and 1, 2, 4‐Benzothiadiazine 1, 1 … JW CHERN, PL TAO, KC WANG, A GUTCAIT, SW LIU, MH YEN, ... ChemInform 29 (49), no-no, 1998 | 9 | 1998 |
Carrier for targeting nerve cells A Rummel, T Weil, A Gutcaits US Patent 10,266,816, 2019 | 8 | 2019 |
Tightly bound to DNA proteins: Possible universal substrates for intranuclear processes N Sjakste, K Bielskiene, L Bagdoniene, D Labeikyte, A Gutcaits, ... Gene, 2011 | 8 | 2011 |
Proteins tightly bound to DNA: new data and old problems N Sjakste, L Bagdoniene, A Gutcaits, D Labeikyte, K Bielskiene, I Trapina, ... Biochemistry (Moscow) 75 (10), 1240-1251, 2010 | 8 | 2010 |
CARRIER FOR TARGETING NERVE CELLS A RUMMEL, T WEIL, A GUTCAITS WO Patent WO/2006/114,308, 2006 | 8* | 2006 |
Synthesis of 2, 3-Dihydroimidazo [1, 2-a] pyridines from 1, 3-Diketones E Suloeva, M Yure, E Gudriniece, M Petrova, A Gutcaits Chemistry of Heterocyclic Compounds 37 (7), 872-875, 2001 | 8 | 2001 |